{
  "success": true,
  "message": "Data fetched successfully",
  "data": {
    "_id": "65e6fc9bd407612ec36a54c9",
    "scheme_name": "Strengthening of Pharmaceuticals Industry- Assistance to Pharmaceutical Industry for Common Facilities (APICF) - Except NER & Hill States",
    "lifecycle_id": "62c3c60835277c79934bd8de",
    "beneficiary_id": "676594226be40cbf522dc16f",
    "created_at": {},
    "modified_at": {},
    "benefits": "Scheme provides incentive of upto 70% of the project cost of the Common Infrastructure Facilities (CIF) or Rs 2000 lakhs, whichever is less.",
    "eligibility": "All existing Pharma clusters and MSMEs and Pharmaceutical manufacturing units in a cluster who have come together to form a Special Purpose Vehicle (SPV) to execute the project of developing common facility.",
    "conditions": "Lease period for land/building must be at least 30 years.SPV must contribute 30% of the project cost, with no duplicate funding.Administrative support assistance can't exceed 5% of the grant-in-aid.Projects to be completed in 2 years.The SPV must have at least 5 pharma units as members and be a separate legal entity registered under the Companies Act or the Registration of Societies Act.The eligible activities under this sub-scheme in order of priority is as under:Research and Development LabsTesting Laboratory for Pharma ProductsEffluent Treatment PlantsLogistic CentresTraining CentreThe Grants-in-Aid shall not be available to any individual production units, if any, owned by a member of the SPV.The combined net worth of all members in the SPV must equal the total grant amount applied for. Additionally, each SPV member must have a net worth at least 1.5 times their proposed equity contribution.The SPV members shall be legally independent entities without any related-party relationship with each other.",
    "govt_id": "62c3c60835277c79934bd90e",
    "ministry_id": "63d3bc7a35277c4edf7fc368",
    "division_id": "62c3c60935277c79934bd924",
    "scheme_id": "65e1bd61d40761673708121b",
    "sub_scheme_id": "65e1bd61d40761673708121c",
    "segment_id": "62c3153d35277c4aa613ba5c",
    "industry_id": "65e1bc426ec7c159b1f3583a",
    "constitution_entity_id": "62c3153d35277c4aa613ba5f",
    "msme": "Both",
    "msme_classification_id": "65c0d3fcefcca74f9b11fef6",
    "listed_unlisted_id": "62c3153d35277c4aa613ba62",
    "age_lower_limit": 0,
    "age_upper_limit": "0",
    "location_id": "67651accaaf8d87645dba3ea",
    "social_category_id": "62c3153d35277c4aa613ba65",
    "gender_id": "62c3153d35277c4aa613ba67",
    "aid_type_id": "62c3153d35277c4aa613ba68",
    "beneficiaries": "All existing Pharma clusters and MSMEs and Pharmaceutical manufacturing units in a cluster who have come together to form a Special Purpose Vehicle (SPV) to execute the project of developing common facility.",
    "prerequisites": "Lease period for land/building must be at least 30 years.SPV must contribute 30% of the project cost, with no duplicate funding.Administrative support assistance can't exceed 5% of the grant-in-aid.Projects to be completed in 2 years.The SPV must have at least 5 pharma units as members and be a separate legal entity registered under the Companies Act or the Registration of Societies Act.The eligible activities under this sub-scheme in order of priority is as under:Research and Development LabsTesting Laboratory for Pharma ProductsEffluent Treatment PlantsLogistic CentresTraining CentreThe Grants-in-Aid shall not be available to any individual production units, if any, owned by a member of the SPV.The combined net worth of all members in the SPV must equal the total grant amount applied for. Additionally, each SPV member must have a net worth at least 1.5 times their proposed equity contribution.The SPV members shall be legally independent entities without any related-party relationship with each other.",
    "program_id": "62c3c60b35277c79934bda3b",
    "nodal_agency": "Department of Pharmaceuticals",
    "who_will_claim_id": "62c3c60b35277c79934bda40",
    "context": "This scheme addresses the demand and requirement for support to already existing pharma clusters and MSMEs to improve productivity, quality and sustainability.",
    "objective": "To strengthen the existing pharmaceutical clusters’ capacity for their sustained growth by creating tangible assets as “Common Facilities”.",
    "description": "Scheme provides incentive of upto 70% of the project cost of the Common Infrastructure Facilities (CIF) or Rs 2000 lakhs, whichever is less.",
    "how_to_apply": "Visit the online portal developed by the Small Industries Development Bank of India (SIDBI), the Project Management Consultant (PMC) for the scheme.Register your application at this portal:- https://spi.udyamimitra.in/",
    "funding_facilitator": "Department of Pharmaceuticals",
    "funding_mechanism": "The applicant will get the benefits in the following installments :1st installment : 30% funds will be released after final project approval2nd installment : 30% funds will be released after submitting bills, with 60% of the 1st instalment utilized and proportionate expenses incurred.3rd installment : 30% funds will be released after submitting bills, 100% utilization of 1st instalment, 60% utilization of 2ns installment4th installment : 10% funds will be released once the SPV has fully mobilized, utilized the entire grant, and spent its full share.",
    "highlights": "Not Applicable",
    "status_id": "62c3153d35277c4aa613ba6b",
    "faq": "https://pharmaceuticals.gov.in/sites/default/files/FAQ-APICF_0.pdf",
    "website": "https://spi.udyamimitra.in/Default/ViewFile/?id=GuidelinesOfSchemeStrengtheningOfPharmaceuticalIndustries(SPI).pdf&path=MiscFiles",
    "additional_info": "SPV shall be responsible for O&M of assets created under the scheme by way of collecting user charges from the members/users.",
    "slug": "strengthening-of-pharmaceuticals-industry--assistance-to-pharmaceutical-industry-for-common-facilities-(apicf)---except-ner-&-hill-states",
    "admin_id": "676505bcf5b1a0244292dbe6",
    "status": "active",
    "custom_fields": [],
    "end_date": "31-03-2026",
    "doi_age_nyi": "DOI",
    "lower_limit": "31-03-1800",
    "upper_limit": "31-03-2100",
    "display_name_id": "67dbad8539ee0415a559c448",
    "is_primary": false,
    "secondary_schemes_details": "",
    "scheme_count": true,
    "category_id": "62c46c0a35277c5303055146",
    "checklist_info_a": "1. Aadhar Card\n2. PAN Card\n3. Voters’ ID \n4. Photographs\n5. Bank details",
    "checklist_info_b": "SIDBI SPI (udyamimitra.in)",
    "checklist_info_c": "Not Applicable",
    "checklist_info_d": "Address:\nShri Hara Kumar Hajong,\nEconomic Adviser ,\nMinistry of Chemicals & Fertilizers,\nDepartment of Pharmaceuticals,\nRoom No. 346, 'A' Wing, Shastri Bhawan, New Delhi\n\nEmail -hk[dot]hajong[at]nic[dot]in\n\nTelephone: 011-23381927\nFax: 011-23384188",
    "sort": "A",
    "count": 256,
    "scheme_benefit_type": "direct",
    "to_deactivate": false,
    "wish_count": 3,
    "scheme_vertical_type": "Subsidy",
    "export": "No",
    "loan": "No",
    "maximum_loan": 0,
    "maximum_others": 0,
    "maximum_subsidy": 2000,
    "start_up": "No",
    "subsidy": "Yes",
    "location": "Andaman and Nicobar Islands, Andhra Pradesh, Bihar, Chhattisgarh, Dadra and Nagar Haveli and Daman & Diu, Delhi, Goa, Gujarat, Haryana, Jharkhand, Karnataka, Kerala, Lakshadweep, Madhya Pradesh, Maharashtra, Odisha, Puducherry, Punjab, Rajasthan, Tamil Nadu, Telangana, Uttar Pradesh, West Bengal",
    "social_category": "All Categories",
    "gender": "All Genders",
    "aid_type": "Capital Subsidy",
    "beneficiary": "Pharma Industry - All Entities - Except NER & Hill States - All MSMEs and All Non-MSMEs",
    "lifecycle": "Establishment of brand and enhance quality output",
    "scheme_status": "Open",
    "scheme_master_name": "Strengthening of Pharmaceuticals Industry",
    "scheme_display_name": [
      {
        "_id": "67dbad8539ee0415a559c448",
        "name": "Assistance to Pharmaceutical Industry for Common Facilities (APICF) - Strengthening of Pharmaceuticals Industry",
        "admin_id": "676505bcf5b1a0244292dbe6",
        "status": "active",
        "created_at": {},
        "modified_at": {}
      }
    ],
    "display_name": "Assistance to Pharmaceutical Industry for Common Facilities (APICF) - Strengthening of Pharmaceuticals Industry"
  }
}